DK523980A - Farmaceutiske midler af terapeutisk vaerdi til behandling af akut lungeoedem nogle choktilstande og hyperfibrinolyse - Google Patents

Farmaceutiske midler af terapeutisk vaerdi til behandling af akut lungeoedem nogle choktilstande og hyperfibrinolyse

Info

Publication number
DK523980A
DK523980A DK523980A DK523980A DK523980A DK 523980 A DK523980 A DK 523980A DK 523980 A DK523980 A DK 523980A DK 523980 A DK523980 A DK 523980A DK 523980 A DK523980 A DK 523980A
Authority
DK
Denmark
Prior art keywords
values
lunged
hyperfibrinolysis
edema
acute
Prior art date
Application number
DK523980A
Other languages
Danish (da)
English (en)
Inventor
G Sportoletti
A Baglioni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of DK523980A publication Critical patent/DK523980A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK523980A 1979-12-28 1980-12-09 Farmaceutiske midler af terapeutisk vaerdi til behandling af akut lungeoedem nogle choktilstande og hyperfibrinolyse DK523980A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT28416/79A IT1127321B (it) 1979-12-28 1979-12-28 Composizione farmaceutiche aventi specifiche proprieta' terapeutiche nei confronti dell'edema polmonare acuto,di alcuni stati di shock e dell'iperfibrinolisi

Publications (1)

Publication Number Publication Date
DK523980A true DK523980A (da) 1981-06-29

Family

ID=11223557

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523980A DK523980A (da) 1979-12-28 1980-12-09 Farmaceutiske midler af terapeutisk vaerdi til behandling af akut lungeoedem nogle choktilstande og hyperfibrinolyse

Country Status (24)

Country Link
US (2) US4308280A (xx)
JP (1) JPS56100717A (xx)
AR (1) AR227297A1 (xx)
AU (1) AU529650B2 (xx)
BE (1) BE886759A (xx)
BR (1) BR8008492A (xx)
CA (1) CA1166160A (xx)
DE (1) DE3027056A1 (xx)
DK (1) DK523980A (xx)
ES (1) ES8205394A1 (xx)
FI (1) FI803995L (xx)
FR (1) FR2472387A1 (xx)
GB (1) GB2066073B (xx)
GR (1) GR72834B (xx)
IE (1) IE50550B1 (xx)
IN (1) IN151731B (xx)
IT (1) IT1127321B (xx)
LU (1) LU83028A1 (xx)
NL (1) NL8006706A (xx)
NO (1) NO803918L (xx)
PH (1) PH16250A (xx)
PT (1) PT72273B (xx)
SE (1) SE8009102L (xx)
ZA (1) ZA807514B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112805A (en) * 1985-11-22 1992-05-12 Labsystems, Oy Pharmaceutical preparation for promoting epithelial healing and prevention of epithelial destruction
IT1201511B (it) * 1985-12-23 1989-02-02 Italfarmaco Spa Derivati citoprotettivi in patologie a base ischemica,loro preparazione e composizioni che li cntengono
GB8929076D0 (en) * 1989-12-22 1990-02-28 Scras Treatment of shock by blocking agents of edrf effect or formation
SE468881B (sv) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
US6613358B2 (en) 1998-03-18 2003-09-02 Theodore W. Randolph Sustained-release composition including amorphous polymer
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB897439A (en) * 1959-05-08 1962-05-30 American Cyanamid Co Compositions for intravenous use for blood clot lysis
JPS514125A (en) * 1974-06-27 1976-01-14 Mitsubishi Chem Ind N22 ashiru ll arugininesuterumatahasono sanfukaenno seizoho

Also Published As

Publication number Publication date
PH16250A (en) 1983-08-16
NO803918L (no) 1981-06-29
US4308280A (en) 1981-12-29
SE8009102L (sv) 1981-06-29
AU6502880A (en) 1981-07-02
IT1127321B (it) 1986-05-21
NL8006706A (nl) 1981-07-16
ES497509A0 (es) 1982-06-16
US4405643A (en) 1983-09-20
GR72834B (xx) 1983-12-07
BE886759A (nl) 1981-04-16
LU83028A1 (de) 1981-03-27
FR2472387A1 (fr) 1981-07-03
IE802606L (en) 1981-06-28
BR8008492A (pt) 1981-07-14
JPS6342603B2 (xx) 1988-08-24
IN151731B (xx) 1983-07-16
GB2066073B (en) 1984-02-01
AU529650B2 (en) 1983-06-16
PT72273B (en) 1981-11-05
CA1166160A (en) 1984-04-24
JPS56100717A (en) 1981-08-12
FI803995L (fi) 1981-06-29
AR227297A1 (es) 1982-10-15
GB2066073A (en) 1981-07-08
IE50550B1 (en) 1986-05-14
DE3027056A1 (de) 1981-07-02
ZA807514B (en) 1981-11-25
IT7928416A0 (it) 1979-12-28
ES8205394A1 (es) 1982-06-16
PT72273A (en) 1981-01-01
FR2472387B1 (xx) 1983-10-07

Similar Documents

Publication Publication Date Title
SE8107291L (sv) Forfarande for behandling av avloppsvatten
NO810814L (no) Apparat og fremgangsmaate for behandling av organiske materialer
SE7809324L (sv) Behandling av forkolningsbart material
NO154764C (no) Gel for behandling av underjordiske formasjoner.
DK175879A (da) Produkt til absorbering og tilbageholdelse af legemfluider
NO152182C (no) Anordning for pumping av tofasefluider
DK198878A (da) Fremgangsmaade til behandling af fjer og cyklon til udfoerelse af fremgangsmaaden
DK461778A (da) Fremgangsmaade og anordning til fremstilling af myseprodukter
DK32680A (da) Plasmabehandlingsapparat
DK34579A (da) Fremgangsmaade og kolonne til gelfiltrering
DK150212C (da) Apparat til behandling af hoestafgroeder
TR20880A (tr) Akrilonitrilin aritilmasi
SE7801315L (sv) Forfarande och anordning for behandling av avloppsvatten
DK523980A (da) Farmaceutiske midler af terapeutisk vaerdi til behandling af akut lungeoedem nogle choktilstande og hyperfibrinolyse
NO803849L (no) Fremgangsmaate til behandling av problemavfall
DK209981A (da) Straalebehandlingsapparat
DK160416C (da) Fremgangsmaade til behandling af raavand og spildevand
DK267078A (da) Fremgangsmaade til fremstilling af n1-glucofuranosid-6-yl-n3-n3-nitrosourinstoffer og derivater deraf
NO814250L (no) Fremgangsmaate til hardgjoering og stabilisering av trevirke
DK293680A (da) Fremgangsmaade og produkt til behandling af jord for at undertrykke nitrifikationen af ammonitrogen deri
SE7810604L (sv) Forfarande for framstellning av kneckebrod jemte anleggning for genomforande av forfarandet
DK151570C (da) Afsvovlningsmiddel og fremgangsmaade til fremstilling deraf
NO791860L (no) Fremgangsmaate og apparat for behandling av alger
NO812937L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomt n-(1-allyl-2-pyrrolidinyl-methyl)-2-methoxy-4-amino-5-methylsulfamoyl-benzamid
SE7804545L (sv) Forfarande for behandling av cereala plantor

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment